Summary
Parathyroid hormone (PTH) alone is known to increase bone mass, but clinical studies of osteoporotic men suggest that when 1,25 dihydroxyvitamin D3 (1,25(OH)2D3) is given in combination with PTH, the effect on bone growth is enhanced. To determine if 1,25(OH)2D3 alone would stimulate bone growth, young male rats were given daily subcutaneous injections of either vehicle or 2.5, 5, 10, or 20 ng 1,25(OH)2D3 per 100 g body weight for 30 days. To determine if 1,25(OH)2D3 would augment the PTH anabolic response, rats were given daily subcutaneous injections of either vehicle for 12 days; or 4 μg/100 g hPTH alone or in combination with 5 ng/100 g 1,25(OH)2D3; or 8 μg/100 g hPTH alone or in combination with 5 ng/100 g 1,25(OH)2D3. Calcium (Ca), dry weight (DW), and hydroxyproline (Hyp) of the distal femur; the rate of mineralization in the metaphysis of the proximal tibia; and serum calcium and phosphate were measured. Low normocalcemic doses of 1,25(OH)2D3 did not significantly stimulate bone growth. 1,25(OH)2D3 did not augment the PTH-stimulated anabolic effect in young male rats. Low doses (2.5 and 5 ng) of 1,25(OH)2D3 were not hypercalcemic, and there was no increase in total bone calcium or dry weight although the 5 ng dose increased trabecular bone calcium. 1,25(OH)2D3 at 10 and 20 ng increased trabecular bone DW and Hyp, but mineralization was impaired and rats were hypercalcemic. 1,25(OH)2D3 in combination with PTH did not augment the PTH stimulation of bone growth as trabecular and cortical bone Ca, DW, and HYP were not increased in rats given both hPTH and 1,25(OH)2D3 compared with values for rats treated with hPTH alone.
Similar content being viewed by others
References
Gunness-Hey M, Hock JM (1984) Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metab Bone Dis Rel Res 5: 177–181
Podbesek R, Edouard C, Meunier PJ, Parsons JA, Reeve J, Stevenson RW, Zanelli JM (1983) Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinol 112: 1000–1006
Hefti E, Trechsel U, Bonjour JP, Fleisch H, Schenk R (1982) Increase of whole body calcium and skeletal mass in normal and osteoporotic adult rats treated with parathyroid hormone. Clin Sci 62: 389–396
Hock JM, Gunness-Hey M, Poser J, Olson H, Bell NH, Raisz LG (1986) Stimulation of undermineralized matrix formation by 1,25-dihydroxyvitamin D3 in long bones of rats. Calcif Tissue Int 38: 79–86
Boyce RW, Weisbrode SE (1983) Effect of dietary calcium on the bone response to 1,25(OH)2D3. Lab Invest 48: 683–689
Gallagher JA, Beneton M, Harvey L, Lawson DEM (1986) Response of rachitic rat bones to 1,25-dihydroxyvitamin D3: biphasic effects on mineralization and lack of effect on bone resorption. Endocrinol 119: 1603–1609
Lindholm TS, Nilsson OS, Lindholm TC (1981) Effect of 1-alpha-hydroxyvitamin D3 on cancellous bone matrix. An experimental study in rats. Acta Orthop Scand 52: 497–503
Wronski TJ, Halloran BP, Bikle DD, Goblus RK, Morey-Holton ER (1986) Chronic administration of 1,25-dihydroxyvitamin D3: increased bone but impaired mineralization. Endocrinol 119: 2580–2585
Larsson SE, Lorentzon R, Boquist L (1977) Low doses of 1,25-dihydroxycholecalciferol increase mature bone mass in adult normal rats. Clin Orthop Rel Res 127: 228–235
Ott SM, Chesnut CH (1987) Calcitriol treatment does not increase bone mass in postmenopausal osteoporotic women. J Bone Min Res 2(suppl 1): 224A
Slovik DM, Rosenthal DI, Doppelt SH, Potts JT Jr, Daly MA, Campbell JA, Neer RM (1986) Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1–34) and 1,25-dihydroxyvitamin D. J Bone Min Res 1: 377–381
Gunness-Hey M, Hock JM, Gera I, Fonseca J, Poser J, Bevan J, Raisz LG (1986) Human parathyroid hormone (1–34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25-dihydroxyvitamin D3. Calcif Tissue Int 38: 234–238
Schmid RN, Reilly CN (1957) New complexion for titration of calcium in the presence of magnesium. Anal Chem 29: 264–268
Belseyre RE, DeLuca HF, Potts JR (1974) A rapid assay for 25(OH)D3 without preparative chromatography. J Clin Endocrinol Metab 38: 1046–1051
Reinhardt TA, Horst RL, Orf JW, Hollis BW (1984) A microassay for 1,25 dihydroxyvitamin D3 not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab 58: 91–98
Cheng PM (1969) An improved method for the determination of hydroxyproline in rat skin. Dermatologica 53: 112–115
Snedecor GW, Cochran WC (1967) Statistical methods. Iowa State University Press, Ames, Iowa
Steel RGD, Torrie JH (1980) Principles and procedures of statistics: a biometrical approach. McGraw-Hill, New York
Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HJ (1979) Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients. Effects of age and dietary calcium. J Clin Invest 64: 729–736
Recker RR, Gallagher JC, Heaney RP (1984) The metabolic effects of treatment with calcitriol in patients with postmenopausal osteoporosis. Clin Res 32: 406A
Gallagher JC, Jerpbak CM, Jee WSS, Johnson KA, DeLuca HF, Riggs BL (1982) 1,25-dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis. Proc Natl Acad Sci (USA) 79: 3325–3329
Reeve J, Arlot M, Bernat M, Charhon S, Edouard C, Slovik D, Vismans J, Meunier PJ (1981) Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1–34) therapy. Metab Bone Dis Rel Res 3: 23–30
Reeve J, Zanelli JM (1986) Parathyroid hormone and bone. Clin Sci 71: 231–238
Malluche HH, Matthews C, Faugere M-C, Fanti P, Endres DB, Friedler RM (1986) 1,25-dihydroxyvitamin D maintains bone cell activity, and parathyroid hormone modulates bone cell number in dogs. Endocrinology 119: 1293–1304
Ambrecht HJ (1986) Age-related changes in calcium and phosphorus uptake by rat small intestine. Biochem Biophys Acta 882: 281–286
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gunness-Hey, M., Gera, I., Fonseca, J. et al. 1,25 dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats. Calcif Tissue Int 43, 284–288 (1988). https://doi.org/10.1007/BF02556637
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02556637